Приказ основних података о документу
Indicator of antibiotic use in Public pharmacy chain Belgrade
dc.creator | Sovtić, D. D. | |
dc.creator | Tasić, Ljiljana | |
dc.creator | Stojanović, S. | |
dc.date.accessioned | 2019-09-02T11:03:52Z | |
dc.date.available | 2019-09-02T11:03:52Z | |
dc.date.issued | 2006 | |
dc.identifier.issn | 1098-3015 | |
dc.identifier.uri | https://farfar.pharmacy.bg.ac.rs/handle/123456789/706 | |
dc.description.abstract | OBJECTIVE: Is to analyze trends in prescription habits and rational use of antibiotics in different population groups, as well as expenditure data regarding drug policy changes. METHODS: We used database from Public pharmacy chain—Pharmacy Insti- tution Belgrade (1.5 M population) with conventional data grouping and database analysis. All information on antibiotics was based on prescriptions which were reimbursed by local Health Insurance Fund (HIF). The calculations included: DDD methods, monetary cost for months, quarters and years level (2004–2005). RESULTS: The use of antibiotics expressed in DDD/1000 inhabitants/day units reveals that in Belgrade popu- lation the most prescribed antibiotic is amoxicillin during two years (4.77 in 2004; 4.37 in 2005). The biggest increase has been shown in the use of azithromycin (from 0.25 in 2004 to 0.75 in 2005). Expenditure of antibiotics was analyzed between six pop- ulation groups (three children’s, two work ages, one senior) and expressed as % of all antibiotics used. The highest financial cost has been found in group of 19–50 years old in both years with levels 26.11% and 32.27% respectively. The first three anti- biotics with highest financial share (monetary cost in % of all antibiotics) are cefalexin 27.46%, erythromycin 17.73%, amox- icillin 13.57% (2004); cefalexin 21.06%, erythromycin 14.59%, azithromycin 14.11% (2005). CONCLUSIONS: Analysis and evaluation of the data has shown that there had been increase in expenditure of antibiotics in these periods particularly in age group 19–50. The biggest increase is notified in the use of azithromycin both in financial values and DDD units, conducted by drug policy changes (reimbursement list). Monitoring of the antibiotics use in longer period can provide further useful infor- mation about rational use of this group of medicines. | |
dc.publisher | Elsevier | |
dc.rights | openAccess | |
dc.source | Value in Health | |
dc.title | Indicator of antibiotic use in Public pharmacy chain Belgrade | en |
dc.type | conferenceObject | |
dc.rights.license | ARR | |
dcterms.abstract | Стојановић, С.; Совтић, Д. Д.; Тасић, Љиљана; | |
dc.citation.volume | 9 | |
dc.citation.issue | 6 | |
dc.citation.spage | A306 | |
dc.citation.epage | A306 | |
dc.citation.other | 9(6): - | |
dc.citation.rank | aM21 | |
dc.description.other | POSTER SESSION II | |
dc.description.other | INFECTION | |
dc.identifier.wos | 000240922000378 | |
dc.identifier.doi | 10.1016/S1098-3015(10)63525-5 | |
dc.identifier.fulltext | http://farfar.pharmacy.bg.ac.rs/bitstream/id/10610/Indicator_of_antibiotic_pub_2006.pdf | |
dc.type.version | publishedVersion |